Latest News

ACS: Breast Cancer Incidence Rising, Mortality Disparities Persist


 

Similar to the ACS report, a recent study published in JAMA Network Open reported rising breast cancer incidence among US women aged 20-49 years of different races in different age groups over the past 2 decades.

The increased incidence of breast cancer in younger women “is an area of concern and an area where we really need to spend more effort trying to understand why,” said lead study author and breast surgeon Adetunji T. Toriola, MD, PhD, MPH, of Washington University in St Louis, Missouri.

Although reproductive and lifestyle factors, such as weight gain, diet, and physical activity, may contribute to the growing breast cancer incidence in younger women — and preliminary findings from Dr. Toriola’s own research suggest that reproductive factors may be a particularly strong driver — environmental factors, including exposure to forever chemicals, may also play a role.

Early-life factors, such as exposure to toxins, remain an underexplored area, Dr. Toriola noted, stressing the importance of teasing out the long-term effects of environmental exposures in puberty and during adolescence.

Overall, the trends observed both in this study and the ACS report highlight the need for enhanced prevention efforts that address racial disparities as well as the rising incidence in young women, said Dr. Toriola, also professor of surgery at the Washington University Institute of Public Health, St Louis.

For now, Dr. Toriola urges women to “engage with mammographic screening as soon as qualified” as per guidelines. Women at average risk should go for screening beginning at age 40, and those with a family history or other risk factors should talk to their physician about earlier screening, he said.

Ms. Giaquinto is employed by the ACS, which receives grants from private and corporate foundations, including foundations associated with companies in the health sector, for research outside of the submitted work. Dr. Toriola reported having no disclosures.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

Starting Mammography at Age 40 May Backfire Due to False Positives
MDedge ObGyn
Cancer Risk: Are Pesticides the New Smoking?
MDedge ObGyn
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
MDedge ObGyn
Black Women Have a Higher Risk for Death in BC Subtypes
MDedge ObGyn
Screening Identifies Familial Risk for Hereditary Breast and Ovarian Cancer in Large Health System
MDedge ObGyn
AACR Cancer Progress Report: Big Strides and Big Gaps
MDedge ObGyn
Does Medicare Advantage Offer Higher-Value Chemotherapy?
MDedge ObGyn
Popular Weight Loss Drugs Now for Patients With Cancer?
MDedge ObGyn
‘Cancer Doesn’t Wait’: How Prior Authorization Harms Care
MDedge ObGyn
The Biology of ‘Precancer’: Stopping Cancer Before It Starts
MDedge ObGyn